Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures

ARTIS Ventures Pioneer Spotlight: Fereydoun Firouz

Delix Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in PhI Trial for DLX-001

Artis Ventures' Bet on Protein-Research Technology

With the Potential to Revolutionize Personalized Health, Range Bio Receives $5.2M Led by ARTIS

ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology

ARTIS Ventures Pioneer Spotlight: Charlene Frizzera

Where does AI fit in the therapeutics discovery equation?

The Keys to Success, As Told By Today’s Top Minds in Biotech, Pharma, and Healthcare

2022 Year in Review

Welcome to our AV Fellows Class of 2022!

ARTIS Ventures Pioneer Spotlight: Michael Yang

ARTIS Portfolio founders named to Forbes 30 Under 30 for Healthcare & Consumer Technology

ARTIS Ventures Pioneer Spotlight: Quita Highsmith

ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team